技术指标
指标
数值
方向
MACD(12,26,9)
0.050
中性
RSI(14)
46.057
中性
STOCH(KDJ)(9,3,3)
66.005
买入
ATR(14)
0.499
低波动
CCI(14)
38.616
中性
Williams %R
41.045
买入
TRIX(12,20)
-0.466
卖出
StochRSI(14)
100.000
超买
搜索
Amarin Corporation PLC
AMRN添加自选
14.260USD
+0.030+0.21%
收盘 07-31 16:00（美东）报价延迟15分钟
301.21M总市值
亏损市盈率 TTM
关键数据
14.180今开
14.400最高
59.62K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.28%换手率
14.230昨收
13.850最低
567.34K成交额
亏损市盈率静
0.68市净率
0.00%股息率 TTM
-5.17%ROA
20.90052周最高
1.05量比
-82.18M净利润
21.00M总股本
-1.6122每股收益TTM
0.82Beta
-7.28%ROE
11.27052周最低
3.87%振幅
35.51%毛利率
301.21M总市值
-3.52回报/风险
2.71%风险率
TradingKey Amarin Corporation PLC股票评分
单位: USD 更新时间: 2026-07-31操作建议
Amarin Corporation PLC当前公司基本面数据相对非常健康，增长潜力较大。当前估值合理，在生物技术与医疗研究行业排名161/385位。机构持股占比非常高，近一月多位分析师给出公司评级为卖出。最高目标价12.00。中期看，股价处于平稳状态。近一个月，市场表现较差，但基本面评分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Amarin Corporation PLC评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
看好
Amarin Corporation PLC亮点
亮点风险
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
分析师目标
根据
1
位分析师
卖出
评级
12.000
目标均价
-26.70%
涨幅空间
Amarin Corporation PLC新闻
即将为您带来更多新闻，敬请期待。。。
收益预测
分析师评级
根据
1
位分析师
卖出
评级
12.000
目标均价
-26.70%
涨幅空间
强力买入
买入
持有
卖出
强力卖出
同行比较
496
总数
6
中位数
7
平均值
公司名称
评级分布
分析师数
Amarin Corporation PLC
AMRN
1
百济神州
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
技术指标
移动平均线
指标
数值
方向
MA5
14.082
买入
MA10
13.880
买入
MA20
14.341
卖出
MA50
14.807
卖出
MA100
14.763
卖出
MA200
15.187
卖出
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Amarin Corporation PLC简介
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
公司代码AMRN
公司Amarin Corporation PLC
CEOBerg (Aaron D)
网址https://amarincorp.com/
公司股东
相关品种
热门品种
常见问题
Amarin Corporation PLC(AMRN)的当前股价是多少？
Amarin Corporation PLC(AMRN)的当前股价是 14.26。
Amarin Corporation PLC的股票代码是什么？
Amarin Corporation PLC的股票代码是AMRN。
Amarin Corporation PLC股票的52周最高点是多少？
Amarin Corporation PLC股票的52周最高点是20.90。
Amarin Corporation PLC股票的52周最低点是多少？
Amarin Corporation PLC股票的52周最低点是11.27。
Amarin Corporation PLC的市值是多少？
Amarin Corporation PLC的市值是301.21M。
现在Amarin Corporation PLC(AMRN)的股票是买入、持有还是卖出？
根据分析师评级，Amarin Corporation PLC(AMRN)的总体评级为卖出，目标价格为12.00。
Amarin Corporation PLC(AMRN)股票的每股收益（EPS TTM）是多少
Amarin Corporation PLC(AMRN)股票的每股收益（EPS TTM）是-37.40。